Puerarin alleviates depressive-like behaviors in high-fat diet-induced diabetic mice via modulating hippocampal GLP-1R/BDNF/TrkB signaling

References

• van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol. 2020;8:325–36.
   PubMed Web of Science ®Google Scholar
• Perrin NE, Davies MJ, Robertson N, Snoek FJ, Khunti K. The prevalence of diabetes-specific emotional distress in people with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2017;34:1508–20.
   PubMed Web of Science ®Google Scholar
• Duarte-Silva E, de Melo MG, Maes M, Chaves AJM, Macedo D, Peixoto CA. Shared metabolic and neuroimmune mechanisms underlying type 2 diabetes mellitus and major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111:110351.
   PubMed Web of Science ®Google Scholar
• Doboszewska U, Wlaz P, Nowak G, Radziwon-Zaleska M, Cui RJ, Mlyniec K. Zinc in the monoaminergic theory of depression: its relationship to neural plasticity. Neural Plast. 2017;2017:1–18.
   Web of Science ®Google Scholar
• Chen R, Wu P, Cai Z, Fang Y, Zhou H, Lasanajak Y, et al. Puerariae Lobatae Radix with chuanxiong Rhizoma for treatment of cerebral ischemic stroke by remodeling gut microbiota to regulate the brain-gut barriers. J Nutr Biochem. 2019;65:101–14.
   PubMed Web of Science ®Google Scholar
• Xu DX, Guo XX, Zeng Z, Wang Y, Qiu J. Puerarin improves hepatic glucose and lipid homeostasis in vitro and in vivo by regulating the AMPK pathway. Food Funct. 2021;12:2726–40.
   PubMed Web of Science ®Google Scholar
• Kong H, Zhang GL, Cheng JJ, Shi RF, Zhang ML, Cao P, et al. Distribution kinetics of puerarin in rat hippocampus after acute local cerebral ischemia. J Pharm Biomed Anal. 2019;164:196–201.
   PubMed Web of Science ®Google Scholar
• Cheng J, Chen M, Zhu JX, Li CF, Zhang QP, Geng D, et al. FGF-2 signaling activation in the hippocampus contributes to the behavioral and cellular responses to puerarin. Biochem Pharmacol. 2019;168:91–9.
   PubMed Web of Science ®Google Scholar
• Tantipongpiradet A, Monthakantirat O, Vipatpakpaiboon O, Khampukdee C, Umehara K, Noguchi H, et al. Effects of puerarin on the ovariectomy-induced depressive-like behavior in ICR mice and its possible mechanism of action. Molecules. 2019;24:4569.
   PubMed Web of Science ®Google Scholar
• Bhuiyan MMH, Haque MN, Mohibbullah M, Kim YK, Moon IS. Radix Puerariae modulates glutamatergic synaptic architecture and potentiates functional synaptic plasticity in primary hippocampal neurons. J Ethnopharmacol. 2017;209:100–7.
   PubMed Web of Science ®Google Scholar
• Wang CJ, Yao JH, Ju LJ, Wen XH, Shu L. Puerarin ameliorates hyperglycemia in HFD diabetic mice by promoting beta-cell neogenesis via GLP-1R signaling activation. Phytomedicine. 2020;70:153222.
   PubMed Web of Science ®Google Scholar
• Detka J, Glombik K. Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression. Pharmacol Rep. 2021;73:1020–32.
   PubMed Web of Science ®Google Scholar
• Hassan AM, Mancano G, Kashofer K, Frohlich EE, Matak A, Mayerhofer R, et al. High-fat diet induces depression-like behaviour in mice associated with changes in microbiome, neuropeptide Y, and brain metabolome. Nutr Neurosci. 2019;22:877–93.
   PubMed Web of Science ®Google Scholar
• Vagena E, Ryu JK, Baeza-Raja B, Walsh NM, Syme C, Day JP, et al. A high-fat diet promotes depression-like behavior in mice by suppressing hypothalamic PKA signaling. Transl Psychiatry. 2019;9:141.
   PubMed Web of Science ®Google Scholar
• Krishnadas R, Cavanagh J. Depression: an inflammatory illness? J Neurol Neurosurg Psychiatry. 2012;83:495–502.
   PubMed Web of Science ®Google Scholar
• Cox LJ, Hengst U, Gurskaya NG, Lukyanov KA, Jaffrey SR. Intra-axonal translation and retrograde trafficking of CREB promotes neuronal survival. Nat Cell Biol. 2008;10:149–59.
   PubMed Web of Science ®Google Scholar
• Semenkovich K, Brown ME, Svrakic DM, Lustman PJ. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment. Drugs. 2015;75:577–87.
   PubMed Web of Science ®Google Scholar
• Wen FK, Crosby K, Miller BH, Rommen M, Kirzner SJ, Hoberecht T, et al. Association of first-line antidepressants and incident adverse metabolic effects. Can Fam Physician. 2020;66:898–900.
   PubMed Web of Science ®Google Scholar
• Nguyen TTH, Roussin A, Rousseau V, Montastruc JL, Montastruc F. Role of serotonin transporter in antidepressant-induced diabetes mellitus: a pharmacoepidemiological–pharmacodynamic study in VigiBase®. Drug Saf. 2018;41:1087–96.
   PubMed Web of Science ®Google Scholar
• Grigolon RB, Brietzke E, Mansur RB, Idzikowski MA, Gerchman F, De Felice FG, et al. Association between diabetes and mood disorders and the potential use of anti-hyperglycemic agents as antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 2019;95:109720.
   PubMed Web of Science ®Google Scholar
• Spohr L, Luduvico KP, Soares MSP, Bona NP, Oliveira PS, de Mello JE, et al. Blueberry extract as a potential pharmacological tool for preventing depressive-like behavior and neurochemical dysfunctions in mice exposed to lipopolysaccharide. Nutr Neurosci. 2022;25:857–70.
   PubMed Web of Science ®Google Scholar
• Cork SC, Richards JE, Holt MK, Gribble FM, Reimann F, Trapp S. Distribution and characterisation of glucagon-like peptide-1 receptor expressing cells in the mouse brain. Mol Metab. 2015;4:718–31.
   PubMed Web of Science ®Google Scholar
• Mansur RB, Lee Y, Subramaniapillai M, Brietzke E, McIntyre RS. Cognitive dysfunction and metabolic comorbidities in mood disorders: a repurposing opportunity for glucagon-like peptide 1 receptor agonists? Neuropharmacology. 2018;136:335–42.
   PubMed Web of Science ®Google Scholar
• Zhang LQ, Zhang W, Li T, Yang T, Yuan XM, Zhou YQ, et al. GLP-1R activation ameliorated novel-object recognition memory dysfunction via regulating hippocampal AMPK/NF-kappa B pathway in neuropathic pain mice. Neurobiol Learn Mem. 2021;182:107463.
   PubMed Web of Science ®Google Scholar
• Fang WT, Zhang J, Hong LY, Huang WB, Dai XM, Ye QY, et al. Metformin ameliorates stress-induced depression-like behaviors via enhancing the expression of BDNF by activating AMPK/CREB-mediated histone acetylation. J Affect Disord. 2020;260:302–13.
   PubMed Web of Science ®Google Scholar
• Morella I, Hallum H, Brambilla R. Dopamine D1 and glutamate receptors co-operate with brain-derived neurotrophic factor (BDNF) and TrkB to modulate ERK signaling in adult striatal slices. Front Cell Neurosci. 2020;14:564106.
   PubMed Web of Science ®Google Scholar
• Dutheil S, Ota KT, Wohleb ES, Rasmussen K, Duman RS. High-fat diet induced anxiety and anhedonia: impact on brain homeostasis and inflammation. Neuropsychopharmacology. 2016;41:1874–87.
   PubMed Web of Science ®Google Scholar
• Arcego DM, Toniazzo AP, Krolow R, Lampert C, Berlitz C, Garcia ED, et al. Impact of high-fat diet and early stress on depressive-like behavior and hippocampal plasticity in adult male rats. Mol Neurobiol. 2018;55:2740–53.
   PubMed Web of Science ®Google Scholar
• Kawai K, Sugimoto K, Nakashima K, Miura H, Ninomiya Y. Leptin as a modulator of sweet taste sensitivities in mice. Proc Natl Acad Sci USA. 2000;97:11044–9.
   PubMed Web of Science ®Google Scholar